Clinical Study

Investigating γ H2AX as a Biomarker of Radiosensitivity Using Flow Cytometry Methods

Table 2

Comparing control to sensitive groups for the dose course experiments. Cells in table represent the geometric mean (and standard deviation) of the fluorescent intensity of the γH2AX signal for each status and dose combination.

Treatment groupDose (Gy)
0246810

CD4a

Control (n = 20)8.83 (1.31)30.73 (6.93)53.91 (10.44)75.92 (17.80)101.98 (26.90)117.81 (31.73)
Sensitive (n = 10)8.83 (2.58)32.53 (7.97)51.37 (11.41)75.33 (17.44)98.44 (19.83)114.41 (30.85)

CD8b

Control (n = 20)8.25 (1.50)24.82 (5.86)42.00 (8.89)57.09 (14.41)76.31 (24.05)86.12 (24.94)
Sensitive (n = 10)7.84 (1.84)25.22 (5.16)38.79 (6.13)53.57 (11.21)70.45 (16.58)82.55 (19.24)

CD19c

Control (n = 20)7.61 (1.59)19.99 (4.81)33.81 (7.90)45.66 (11.69)59.37 (18.40)66.38 (20.61)
Sensitive (n = 10)6.97 (2.15)21.07 (5.73)31.82 (6.39)42.91 (9.79)55.31 (10.43)62.32 (15.43)

Lymphocytesd

Control (n = 20)8.39 (1.29)26.49 (6.17)45.08 (9.49)61.32 (15.44)81.72 (24.08)92.39 (26.90)
Sensitive (n = 10)8.32 (2.20)27.61 (6.32)42.10 (7.44)58.83 (11.93)75.97 (14.23)87.49 (21.26)

Overall status effect: a (P value) = 0.06 (0.81), b (P value) = 0.38 (0.54), c (P value) = 0.33 (0.57), ), and d (P value) = 0.29 (0.59).
Overall difference between status groups at various dose groups: a (P value) = 0.18 (0.97), b (P value) = 0.33 (0.89), c (P value) = 0.42 (0.84), and d (P value) = 0.42 (0.84).